Literature DB >> 19513609

Targeted induction of differentiation of human bone mesenchymal stem cells into neuron-like cells.

Zhaohui Cheng1, Qixin Zheng, Weici Wang, Xiaodong Guo, Yongchao Wu, Jin Zheng.   

Abstract

A systematic method of isolating and culturing human bone mesenchymal stem cells (hMSCs), and inducing them to differentiate into neuron-like cells in vitro was established. The hMSCs were isolated from bone marrow with the lymphocyte-separating medium, cultured and expanded in vitro, and induced after addition of compound neuro-revulsants. The morphological changes of hMSCs were observed, and the expression of surface markers in induced hMSCs was immunocytochemically identified during induction period. The hMSCs could be separated, cultured and expanded in vitro. After induction by compound neuro-revulsants for 48 h, the changes of neuron-like cells, such as cellular shrinkage and neurite growth, were observed in some cells. The immunochemical staining revealed nestin (+) or NF (+), and GFAP (-). It was concluded that hMSCs were successfully cultured and induced to differentiate into neuron-like cells.

Entities:  

Mesh:

Year:  2009        PMID: 19513609     DOI: 10.1007/s11596-009-0306-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  22 in total

Review 1.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

Review 2.  Mesenchymal stem cells.

Authors:  H Kalervo Väänänen
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

3.  Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages.

Authors:  Damien D Pearse; Francisco C Pereira; Anna Stolyarova; David J Barakat; Mary Bartlett Bunge
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

Review 4.  Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review.

Authors:  T K McIntosh
Journal:  J Neurotrauma       Date:  1993       Impact factor: 5.269

5.  Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins.

Authors:  H J Senn; M Orth; E Fitzke; H Wieland; W Gerok
Journal:  Eur J Biochem       Date:  1989-05-15

6.  In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.

Authors:  W Deng; M Obrocka; I Fischer; D J Prockop
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

7.  In vitro expansion of a multipotent population of human neural progenitor cells.

Authors:  M K Carpenter; X Cui; Z Y Hu; J Jackson; S Sherman; A Seiger; L U Wahlberg
Journal:  Exp Neurol       Date:  1999-08       Impact factor: 5.330

Review 8.  [Future views and challenges to the peripheral nerve regeneration by cell based therapy].

Authors:  Mari Dezawa
Journal:  Rinsho Shinkeigaku       Date:  2005-11

9.  Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation.

Authors:  Z S Li; T D Pham; H Tamir; J J Chen; M D Gershon
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

Review 10.  Neural tissue engineering: strategies for repair and regeneration.

Authors:  Christine E Schmidt; Jennie Baier Leach
Journal:  Annu Rev Biomed Eng       Date:  2003       Impact factor: 9.590

View more
  2 in total

1.  Effect of IKVAV peptide nanofiber on proliferation, adhesion and differentiation into neurocytes of bone marrow stromal cells.

Authors:  Bin Wu; Qixin Zheng; Yongchao Wu; Xiaodong Guo; Zhenwei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

2.  Neurogenesis of neural crest-derived periodontal ligament stem cells by EGF and bFGF.

Authors:  Veronica R Fortino; Ren-Shiang Chen; Daniel Pelaez; Herman S Cheung
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.